The ACI welcomes the recent clarifications from The Advisory Council for Novel Foods and Processes (ACNFP) relating to the data requirements for CBD novel foods applications. The ACNFP, who are an advisory committee to the FSA, highlighted the following key points, which emphasise the importance of ACI’s consortium approach to generating this data.
Today the Association for the Cannabinoid Industry (ACI), in partnership with Advanced Development and Safety Laboratory (ADSL), is announcing the launch of a landmark study with a consortium of CBD companies who are together committed to building a sustainable, safe and fully compliant industry in the UK.
The ACI today welcomes the guidance issued by the Food Standards Agency today which fully validates our consortium approach to generating toxicology safety study data for novel foods applications for CBD in line with the requirements of the Government Committee on Toxicity.
With just 6 months remaining, for CBD companies to have a valid novel foods application for each of their products, the ACI has received confirmation from the FSA that these dossiers must include toxicology safety study data and literature-based information is not sufficient.
The ACI will host their latest in a series of webinars on 22 September, in conjunction with the UK’s leading magazine for the FMCG industry, The Grocer and one of North America’s most established cannabis companies, Columbia Care.
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.
The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.
The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.
The ACI have received clarification from the FSA on several points concerning novel foods dossier applications that have been raised by our members.
The ACI announces high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on the development of a cannabinoid testing methodology with a higher precision control, an essential step towards standardisation for the industry.
